DE3260567D1 - Analgesic potentiation - Google Patents

Analgesic potentiation

Info

Publication number
DE3260567D1
DE3260567D1 DE8282301337T DE3260567T DE3260567D1 DE 3260567 D1 DE3260567 D1 DE 3260567D1 DE 8282301337 T DE8282301337 T DE 8282301337T DE 3260567 T DE3260567 T DE 3260567T DE 3260567 D1 DE3260567 D1 DE 3260567D1
Authority
DE
Germany
Prior art keywords
analgesic potentiation
zomepirac
analgesic
potentiation
nonanalgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282301337T
Other languages
English (en)
Inventor
Joseph Francis Gardocki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho McNeil Pharmaceutical Inc
Original Assignee
McNeilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeilab Inc filed Critical McNeilab Inc
Application granted granted Critical
Publication of DE3260567D1 publication Critical patent/DE3260567D1/de
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE8282301337T 1981-03-17 1982-03-16 Analgesic potentiation Expired DE3260567D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/244,562 US4338324A (en) 1981-03-17 1981-03-17 Analgesic potentiation

Publications (1)

Publication Number Publication Date
DE3260567D1 true DE3260567D1 (en) 1984-09-20

Family

ID=22923263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282301337T Expired DE3260567D1 (en) 1981-03-17 1982-03-16 Analgesic potentiation

Country Status (9)

Country Link
US (1) US4338324A (de)
EP (1) EP0061287B1 (de)
JP (1) JPS57159715A (de)
KR (1) KR830008678A (de)
AT (1) ATE8966T1 (de)
AU (1) AU551108B2 (de)
CA (1) CA1178888A (de)
DE (1) DE3260567D1 (de)
PH (1) PH16941A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
JP2002504505A (ja) * 1998-02-25 2002-02-12 アボット・ラボラトリーズ ブトルファノール持続放出性製剤
US20040198723A1 (en) * 2002-01-22 2004-10-07 Karen Gibson Method of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006845B1 (de) * 1978-07-10 1982-02-03 McNeilab, Inc. Ein pharmazeutisches Präparat enthaltend ein Derivat einer 5-Aroyl-1-C1-5 alkyl-pyrrol-2-Essigsäure und Acetaminophen oder Acetylsalicylsäure
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233313A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation

Also Published As

Publication number Publication date
EP0061287A1 (de) 1982-09-29
PH16941A (en) 1984-04-24
EP0061287B1 (de) 1984-08-15
KR830008678A (ko) 1983-12-14
US4338324A (en) 1982-07-06
JPS57159715A (en) 1982-10-01
ATE8966T1 (de) 1984-09-15
AU551108B2 (en) 1986-04-17
CA1178888A (en) 1984-12-04
AU8159882A (en) 1982-09-23

Similar Documents

Publication Publication Date Title
ZA82124B (en) Bandage for administering beneficial drug
GB8326878D0 (en) Administering medicaments to patients
GB8602264D0 (en) Administering medicaments to patients
EP0143977A3 (en) Bilobalid for use as a therapeutic substance
NL7903824A (nl) Samenstelling voor de therapeutische behandeling van chronische uremiepatienten, die periodiek een hemodialyse ondergaan.
IL63036A (en) Dosage units for oral administration
DK0785769T3 (da) Terapeutisk vitamin-calcium-kombination i form af en galenisk enhedsdosistablet, fremgangsmåde til fremstilling af denne sa
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
NZ326345A (en) Composition containing diosgenin
DE3260567D1 (en) Analgesic potentiation
HU9203022D0 (en) Pharmaceutical preparatives with upriflavone content methods for production and medical utilization of said compounds
IE901780L (en) Dehydrocholecalciferol derivatives
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
KR950013453B1 (en) Composition containing 15-deoxisper gualine
ZA837318B (en) Device for administering medicaments to patients
IT1224250B (it) Associzione del depiprazolo con la morfina
ES481109A1 (es) Un metodo de preparacion de un extracto de stephania cepha- rantha.
GB2093345B (en) A topical use composition for the treatment of seborrhea affections of the human scalp
IE811891L (en) Treating insufficiencies in hematosis
JPS53149441A (en) Cosmetic device
ZA833721B (en) Administering fluid to patients
IT8223013V0 (it) Dispositivo per determinare l'intervallo di tempo per la somministrazione di dibecacina solfato in funzione della alterata funzionalita' renale di un paziente.
JPS57123119A (en) Medicinal composition for self immunological disease treatment

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee